Table 2.
Relation between clinicopathological features and expression of miR-301 and PTEN in ESCC patients
| Clinicopathological feature | N | Expression of miR-301 | P value | PTEN mRNA expression | P value | ||
|---|---|---|---|---|---|---|---|
| High expression (n = 55) |
Low expression (n = 55) |
High expression (n = 55) |
Low expression (n = 55) |
||||
| Age (years) | |||||||
| > 60 | 84 | 44 | 40 | 0.501 | 41 | 43 | 0.823 |
| ≤ 60 | 26 | 11 | 15 | 14 | 12 | ||
| Gender | |||||||
| Male | 78 | 37 | 41 | 0.529 | 36 | 42 | 0.294 |
| Female | 32 | 18 | 14 | 19 | 13 | ||
| TNM stage | |||||||
| I + II | 60 | 20 | 40 | < 0.001 | 38 | 22 | 0.004 |
| III | 50 | 35 | 15 | 17 | 33 | ||
| LNM | |||||||
| No | 71 | 27 | 44 | 0.001 | 38 | 23 | 0.007 |
| Yes | 39 | 28 | 11 | 17 | 32 | ||
| Tumor size (cm) | |||||||
| ≥ 5 | 65 | 35 | 30 | 0.438 | 29 | 36 | 0.244 |
| < 5 | 45 | 20 | 25 | 26 | 19 | ||
| Tumor differentiation | |||||||
| Moderate and high differentiation | 78 | 35 | 43 | 0.141 | 44 | 34 | 0.058 |
| Poor differentiation | 32 | 20 | 12 | 11 | 21 | ||
| Tumor location | |||||||
| Upper | 13 | 8 | 5 | 0.556 | 5 | 8 | 0.556 |
| Mid-lower | 97 | 47 | 50 | 50 | 47 | ||
TNM, tumor–node–metastasis; LNM, lymph node metastasis